Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rio

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
AJNR. American Journal of Neuroradiology|April 20, 2023
Assessing the Equivalence of Brain-Derived Measures from Two 3D T1-Weighted Acquisitions: One Covering the Brain and One Covering the Brain and Spinal CordD Pareto, J F Corral, A Garcia-Vidal, et al.
European Journal of Neurology|May 25, 2013
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatmentS Malhotra, C Morcillo-Suárez, R Nurtdinov, et al.
European Journal of Neurology|July 1, 2020
Optical coherence tomography measures correlate with brain and spinal cord atrophy and multiple sclerosis disease-related disabilityA Vidal-Jordana, D Pareto, S Cabello, et al.
AJNR. American Journal of Neuroradiology|April 27, 2000
Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosisM Tintoré, A Rovira, M J Martínez, et al.
Stroke|December 1, 1994
Value of immunologic testing in stroke patients. A prospective multicenter studyJ Montalbán, J Rio, M Khamastha, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 27, 2012
Scoring treatment response in patients with relapsing multiple sclerosisM P Sormani, J Rio, M Tintorè, et al.
Genes and Immunity|March 6, 2003
Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosisU Sriram, L F Barcellos, P Villoslada, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?R Pelayo, X Montalban, T Minoves, et al.
Revista De Neurologia|March 10, 2011
An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosisA Horga, J Castillo, J Rio, et al.
Ophthalmology|April 25, 2012
Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patientsManuel Díaz-Llopis, David Salom, Carmen Garcia-de-Vicuña, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
AJNR. American Journal of Neuroradiology|April 20, 2023
Assessing the Equivalence of Brain-Derived Measures from Two 3D T1-Weighted Acquisitions: One Covering the Brain and One Covering the Brain and Spinal CordD Pareto, J F Corral, A Garcia-Vidal, et al.
European Journal of Neurology|May 25, 2013
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatmentS Malhotra, C Morcillo-Suárez, R Nurtdinov, et al.
European Journal of Neurology|July 1, 2020
Optical coherence tomography measures correlate with brain and spinal cord atrophy and multiple sclerosis disease-related disabilityA Vidal-Jordana, D Pareto, S Cabello, et al.
AJNR. American Journal of Neuroradiology|April 27, 2000
Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosisM Tintoré, A Rovira, M J Martínez, et al.
Stroke|December 1, 1994
Value of immunologic testing in stroke patients. A prospective multicenter studyJ Montalbán, J Rio, M Khamastha, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 27, 2012
Scoring treatment response in patients with relapsing multiple sclerosisM P Sormani, J Rio, M Tintorè, et al.
Genes and Immunity|March 6, 2003
Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosisU Sriram, L F Barcellos, P Villoslada, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?R Pelayo, X Montalban, T Minoves, et al.
Revista De Neurologia|March 10, 2011
An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosisA Horga, J Castillo, J Rio, et al.
Ophthalmology|April 25, 2012
Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patientsManuel Díaz-Llopis, David Salom, Carmen Garcia-de-Vicuña, et al.
Pageof 4